Lactobacillus plantarum AR495 is a widely used probiotic in treating various digestive diseases, including irritable bowel syndrome (IBS). However, the specific mechanisms of L. plantarum AR495 relieving IBS remain unclear. The intestinal abnormal tryptophan metabolism could cause disordered immune response, gastrointestinal peristalsis, digestion and sensation, which closely related to IBS pathogenesis. The aim of this study was to explore the effects and mechanisms of L. plantarum AR495 on regulating tryptophan metabolism. Primarily, tryptophan and its related metabolites in IBS patients and healthy people were analyzed, and the IBS rat model of acetic acid enema plus restraint stress was established to explore the alleviation pathway of L. plantarum AR495 on tryptophan metabolism. It was found that 5-HT pathway was significantly changed in feces of IBS population, and the 5-HTP and 5-HT metabolites were significantly increased, which results also existed in IBS rat model. Maladjusted 5-HT could increase the intestinal peristalsis and lead to the increase of fecal water content and shapeless stool in rats. On the contrary, these two metabolites could be restored to normal level by intragastric administration of L. plantarum AR495. Further study of the metabolic pathway showed that L. plantarum AR495 could effectively reduce the abundance of 5-HT by inhibiting the expression of enterochromaffin cells rather than promoting its decomposition. In addition, the results showed that L. plantarum AR495 did not affect the expression of SERT. To sum up, L. plantarum AR495 could restore the abundance of 5-HT by inhibiting the abnormal proliferation of enterochromaffin cells and the excessive activation of TPH1 to inhibit the intestinal peristalsis of IBS. This finding would provide more evidence for the use of probiotics in IBS and other diarrheal diseases.